Safety of Liposome Extended-Release Bupivacaine for Postoperative Pain Control

Safety of Liposome Extended-Release Bupivacaine for Postoperative Pain Control

Background: Ideal postoperative pain management requires a multidisciplinary approach in combination with a variety of dosage regimens. Approximately 21-30% of patients experience moderate to severe pain in the postoperative period, which may have a significant impact on recovery rate, standard of l...

Full description

Bibliographic Details
Main Authors: Juan Guillermo Portillo, Nawal eKamar, Somayah eMelibary, Eduardo eQuevedo, Sergio Daniel Bergese
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-04-01
Series:Frontiers in Pharmacology
Subjects:
Bupivacaine
DepoFoam
liposome bupivacaine
bupivacaine HCl
and Exparel.
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00090/full

Similar Items

Similar Items